EMA recommends marketing authorization for donanemab (Kisunla)
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
News
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Featured news
The 78th World Health Assembly agrees to extend the Global Action Plan on the Public Health Response to Dementia
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
ADI and DAI join others in statement to WHO about non-communicable diseases and the global COVID-19 response
Alzheimer’s Disease International (ADI) and partner Dementia Alliance International (DAI) join other civil society organisations in a statement to the World Health Organization (WHO).
ADI submits statement on dementia and COVID-19 ahead of World Health Assembly
In advance of the 73rd World Health Assembly, ADI is sharing a statement submitted to the World Health Organization (WHO) and Member States.
New blood test research for diagnosis of Alzheimer’s disease shows promising results
A new study in the Lancet Neurology has shown that blood phosphorylated tau 181 may be a promising biomarker for Alzheimer’s disease.
ADI welcomes new Associations and Board members
ADI welcomes three new Alzheimer associations, as well as new members to the ADI board.
ADI releases a position paper on COVID-19 and dementia
ADI releases a position paper on the difficult decisions people with dementia, their families and carers are having to make around hospital admission and triage during COVID-19.
Italy in crisis: ADI member Alzheimer Italia on the impact of COVID-19 on people with dementia and how they have adapted to support them
Mario Possenti, CEO of ADI’s member Federazione Alzheimer Italia shares his gratitude to the Italian health workforce for their support of people living with dementia in the wake of the COVID-19 crisis.
ADI member CEAFA reveals how they have adapted to support people living with dementia during COVID-19
Jesús Rodrigo, CEO of ADI’s member Confederación Española de Familiares de Enfermos de Alzheimer (CEAFA) shares his experiences of supporting people with dementia and their carers during the COVID-19 outbreak.
COVID-19: Sharing experience and advice from ADI’s member association in China
Professor Huali Wang of Alzheimer's Disease Chinese (ADC) explains how China has addressed the specific challenges of people living with dementia during COVID-19.